Robot-assisted esophagectomy may significantly reduce the incidence of recurrent laryngeal nerve palsy and is expected to further reduce postoperative complications and potentially improve long-term outcomes.
Abstract
Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications
Following the results of the JCOG1409 trial, thoracoscopic esophagectomy has become the standard treatment for esophageal cancer. However, the introduction of robot-assisted esophagectomy is expected to further reduce postoperative complications and potentially improve long-term outcomes.
We retrospectively analyzed 328 consecutive patients who underwent minimally invasive esophagectomy with gastric conduit reconstruction for thoracic esophageal cancer or esophagogastric junction cancer at our institution between January 2017 and September 2025. Patients were divided into two groups: thoracoscopic esophagectomy (Group A) and robot-assisted esophagectomy (Group B). Short-term outcomes were compared between the two groups.
Of the 328 patients, 170 (51.8%) were in Group A and 158 (48.2%) in Group B. There were no significant differences in baseline characteristics, including median age (A vs. B: 69 vs. 70 years) and sex (male/female: 153/17 vs. 137/21). Perioperative factors (A vs. B) showed no significant differences in median operative time (537.5 vs. 548.5 minutes) or median blood loss (148 vs. 131 mL). Postoperative complications were also comparable: pneumonia (CD grade ≥2) occurred in 23 patients (13.5%) vs. 16 patients (10.1%), and anastomotic leakage (CD grade ≥2) occurred in 18 (10.6%) vs. 23 (14.6%) in Groups A and B, respectively. Recurrent laryngeal nerve palsy was significantly less frequent in Group B, both for CD grade ≥1 (18 [10.6%] vs. 7 [4.4%], p=0.036) and CD grade ≥2 (7 [4.1%] vs. 1 [0.6%], p=0.041). The median postoperative hospital stay was 23 days in both groups, with no significant difference.
Robot-assisted esophagectomy may significantly reduce the incidence of recurrent laryngeal nerve palsy. A randomized controlled trial is currently ongoing to further validate these findings and generate robust evidence.
Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications
Although the clinical application of robot-assisted esophagectomy (RE) has increased globally, its advantages over conventional thoracoscopic esophagectomy (TE) remain unclear. The aim of this study was to evaluat...
Daisuke Kurita, Y. Seto, Y. Hirano et al.· Diseases of the esophagus· 0 citations
RAMIE can be safely performed for thoracic esophageal cancer and esophagogastric junction cancer, contributing to the reduction of postoperative complications without compromising curative outcomes and to evaluate the clinical utility of RAMIE.
Hirotoshi Kikuchi, Yuki Sakai, Ryoma Haneda et al.· Diseases of the esophagus· 0 citations
Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes
The number of robot-assisted minimally invasive esophagectomy (RAMIE) performed in Japan is increasing due to its potential advantages. We introduced RAMIE in 2019 and have standardized the technique, including linear-stapled i...
Hiroshi Okabe, Yuya Takabe, Hideki Sunagawa· Diseases of the esophagus· 0 citations
Open and hybrid approaches showed comparable TO attainment, while RAMIE had lower rates, though differences were not statistically significant, which highlight opportunities for optimisation during robotic esophagectomy adoption.
J. Chmelo, Isabel Miglior, Natawadee Chantima et al.· Diseases of the esophagus· 0 citations
Esophageal Cancer: Surgical Treatment of Esophageal Cancer
In order to achieve a radical lymph node dissection, we introduced the transthoracic minimally invasive esophagectomy (TMIE) with hybrid position and TMIE with extensive lymph node dissection have been routinely conducted. We previously reported th...
Yosuke Morimoto, Kazuaki Matsui, M. Takeuchi et al.· Diseases of the esophagus· 0 citations
Esophageal Cancer: Surgical Treatment of Esophageal Cancer
Gastrointestinal complications related to gastric conduit reconstruction adversely affect quality of life (QoL) in patients undergoing esophagectomy for esophageal cancer (EC). We introduced a robot-assisted extended free jejunal interposition (EFJ...
Xinyu Yang, Bin Li, Zhi-Gang Li· Diseases of the esophagus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.